Monitoring gene expression during a Galleria mellonella bacterial infection by Moya-Andérico, Laura et al.
microorganisms
Article
Monitoring Gene Expression during a
Galleria mellonella Bacterial Infection
Laura Moya-Andérico 1,* , Joana Admella 1 , Rodrigo Fernandes 1 and Eduard Torrents 1,2,*
1 Bacterial Infections and Antimicrobial Therapies Group, Institute for Bioengineering of Catalonia (IBEC),
The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain;
jadmella@ibecbarcelona.eu (J.A.); rgaspar@ibecbarcelona.eu (R.F.)
2 Microbiology Section, Department of Genetics, Microbiology, and Statistics, Faculty of Biology, University of
Barcelona, 08028 Barcelona, Spain
* Correspondence: lmoya@ibecbarcelona.eu (L.M.-A.); etorrents@ibecbarcelona.eu (E.T.)
Received: 27 October 2020; Accepted: 13 November 2020; Published: 16 November 2020 
Abstract: Galleria mellonella larvae are an alternative in vivo model that has been extensively used
to study the virulence and pathogenicity of different bacteria due to its practicality and lack of
ethical constraints. However, the larvae possess intrinsic autofluorescence that obstructs the use
of fluorescent proteins to study bacterial infections, hence better methodologies are needed. Here,
we report the construction of a promoter probe vector with bioluminescence expression as well as
the optimization of a total bacterial RNA extraction protocol to enhance the monitoring of in vivo
infections. By employing the vector to construct different gene promoter fusions, variable gene
expression levels were efficiently measured in G. mellonella larvae at various time points during the
course of infection and without much manipulation of the larvae. Additionally, our optimized RNA
extraction protocol facilitates the study of transcriptional gene levels during an in vivo infection. The
proposed methodologies will greatly benefit bacterial infection studies as they can contribute to a
better understanding of the in vivo infection processes and pathogen–mammalian host interactions.
Keywords: Galleria mellonella; P. aeruginosa; hemolymph; hemocytes; bioluminescence; promoter
probe vector; optimized RNA extraction; ribonucleotide reductases
1. Introduction
Galleria mellonella (greater wax moth) is a popular animal model for the study of virulence and
pathogenicity of different bacteria. The larvae are conveniently sized for manipulation, they do not
require feeding, and they are inexpensive to purchase and breed. Moreover, they do not need any
special infrastructure, they present a low biohazard risk, and they are more ethically accepted than
the traditional murine models [1,2]. With an innate immune response very similar to the one found
in mammals, G. mellonella larvae possess both cellular and humoral defenses [3]. Furthermore, they
are also widely used for testing the efficacy and toxicity of new antimicrobial agents, thus offering
an additional pre-screening model to lower the number of drug tests performed in mammalian
animals [4,5]. Based on all these advantages, G. mellonella has recently become an attractive alternative
infection model for gathering initial data.
Studying a bacterial infection in G. mellonella larvae can also be challenging due to some methodological
limitations. The use of bacterial strains containing GFP (green fluorescent protein) vectors has been widely
considered as GFP-tagged bacteria are easily visualized in confocal and fluorescent microscopes, thus
allowing bacteria to be tracked within the hemolymph and hemocytes of the larvae [6,7]. The fluorescence
of bacteria within infected larvae has also been measured with a spectrophotometer [8]. Unfortunately,
most of the studies overlook that G. mellonella larvae possess natural green and red autofluorescence [8,9].
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Therefore, the use of green and red fluorophores is associated with background autofluorescence problems
that hinder the real measurement of bacterial fluorescence. For this reason, bioluminescence currently
seems like the best methodology alternative to monitor an in vivo infection in G. mellonella. Bioluminescence
is a rapid, cost-effective, and non-invasive imaging technique based on the synthesis of light derived from
the luxCDABE operon’s presence in bacteria [10]. The use of vectors that can confer a genetically encoded
luminescent phenotype to bacterial strains has already been reported in the literature [11,12].
Galleria mellonella has been recognized as a suitable model for studying Pseudomonas aeruginosa
infections [13]. Currently one of the most multidrug-resistant pathogens alive, it is also a formidable
opportunistic pathogen that can cause invasive and fulminant infections, such as acute pneumonia or
bloodstream infections, especially in immunocompromised hosts. Remarkably, the same pathogen
also causes chronic infections that can persist for months to decades, such as chronic lung infections
in individuals who have a genetic disease such as cystic fibrosis [14]. P. aeruginosa divides rapidly
during its infection, requiring a high and persistent supply of dNTPs to replicate its DNA quickly.
Ribonucleotide reductases (RNRs) are key enzymes that catalyze the reduction of ribonucleotides to
deoxyribonucleotides, thus providing the precursor molecules needed for DNA synthesis and repair.
There are three RNR classes (I, II, and III), which are encoded by the nrdAB, nrdJab, and nrdDG genes,
respectively. Curiously, P. aeruginosa is one of the few organisms that encode all three classes (Ia, II,
and III) in its genome. Although how each RNR class works is not yet completely understood, it is
established that a particularly tight regulation is required to guarantee bacterial viability. RNR gene
expression is controlled by NrdR, a transcriptional factor that binds to NrdR boxes in the promoter
regions of the different nrd genes and is key for the transcriptional regulation of RNRs [15,16].
Here, we report the construction and utilization of several lux vectors containing different nrd promoter
fusions as a better approach to study and monitor a P. aeruginosa in vivo infection in Galleria mellonella.
Additionally, we optimized a protocol for the isolation of total bacterial RNA during a G. mellonella
infection. The optimized methodologies will be valuable for the study of different infections and further
applications in G. mellonella.
2. Materials and Methods
2.1. Bacterial Strains, Plasmids, and Growth Conditions
The bacterial strains and plasmids used in this study are listed in Table S1. E. coli and P. aeruginosa
cells were routinely grown in Luria-Bertani (LB; Scharlab, Barcelona, Spain) medium at 37 ◦C. Antibiotics
were added when required at the following concentrations: ampicillin, 50 µg/mL; and gentamicin,
10 µg/mL (E. coli) and 100 µg/mL (P. aeruginosa).
2.2. Recombinant DNA and PCR Methods
Recombinant DNA manipulations were performed using standard procedures [17] and following
the manufacturers’ instructions. DNA fragments were amplified by PCR using Phusion™High-Fidelity
DNA Polymerase (Thermo Scientific, Madrid, Spain) for cloning and DreamTaq Green PCR Master Mix
(Thermo Scientific, Madrid, Spain) for colony PCR. All primers used in this study are listed in Table S2.
Isolation of DNA fragments from agarose gels was carried out using the Monarch® DNA Gel Extraction
Kit (New England BioLabs, Ipswich, MA, USA). DNA fragments were digested with corresponding
restriction enzymes (Thermo Scientific, Madrid, Spain) and ligated with T4 DNA ligase (Invitrogen,
Carlsbad, CA, USA). Plasmid DNA was isolated using the GeneJET™ Plasmid Miniprep Kit (Thermo
Scientific, Madrid, Spain) and quantified using a NanoDrop™ 1000 spectrophotometer (Thermo
Scientific, Madrid, Spain). DNA was transformed into P. aeruginosa PAO1 cells by electroporation using
a Gene Pulser Xcell™ electroporator (Bio-Rad, Hercules, CA, USA) as previously described [18].
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2.3. Construction of Promoter Probe Vector with Bioluminescence Expression
Specific restriction site sequences were incorporated as needed at the 5′ ends of primers to facilitate
cloning of fragments into the corresponding vector. The correct insertion of the fragments at each step was
verified by colony PCR and DNA sequencing. The promoter probe vector pETS220-BIATlux (pETSlux)
containing bioluminescence expression was made by first cloning the SacI-KpnI fragment containing
the luxCDABE operon part of pMDM513 into the pBAM-Gm vector. From here, the luxCDABE genes
(6109 bp, without promoter) were amplified by PCR using the Lux_SmaI_fw/pBAM-Gm up primers,
and the amplicon was ligated into the pJET1.2 vector. Meanwhile, the pETS130 vector was digested
with HindIII to remove the chloramphenicol acetyltransferase (cat) and GFP (mut3-GFP variant) genes.
Both the resulting vector and the pJET1.2 vector containing the luxCDABE genes were digested with
HindIII and ligated together to generate the pETSlux. The nucleotide sequence of the pETS220-BIATlux
vector was deposited in GenBank (accession number MW117147).
2.4. Construction of nrd Promoter Fusions
Each nrd promoter region was amplified from P. aeruginosa PAO1 genomic DNA by PCR using a
combination of forward and reverse primers that are listed in Table S2. Each fragment (785 bp, 395 bp,
189 bp, 273 bp, and 333 bp for nrdA, nrdJ, nrdD, nrdR, and anr, respectively) was gel purified and cloned
into the pJET1.2 vector. After digestion with EcoRI-SmaI for nrdA, SmaI-SacI for nrdJ, and EcoRI-SacI for
nrdD, nrdR, and anr, fragments were ligated into pETSlux, generating the pETS221, pETS222, pETS223,
pETS224, and pETS225 plasmids.
2.5. Galleria mellonella Maintenance and Injection
G. mellonella larvae were fed an artificial diet (15% corn flour, 15% wheat flour, 15% infant cereal,
11% powdered milk, 6% brewer’s yeast, 25% honey, and 13% glycerol) and reared at 34 ◦C in darkness
as previously published [9]. To prepare the injection inoculum, the bacterial broth of the different
strains was centrifuged at 4000× g rpm for 10 min. The supernatant was discarded, and the pellet was
re-suspended in 5 mL of 1× PBS (Fisher Scientific, Madrid, Spain) during three washes. OD590 was
measured using a 1/10 dilution with 1x PBS and equalized to a final OD590 of 1. Afterward, 10-fold
serialized dilutions of the equalized culture were made with 1× PBS. G. mellonella larvae (200–220
mg each) were injected with 20–40 CFUs per larva through the top right proleg using a 26-gauge
microsyringe (Hamilton, Reno, NV, USA). Groups of 3–6 larvae were injected for each condition and
kept at 37 ◦C during the infection course.
2.6. Fluorescence Quantification and Microscopy
G. mellonella larvae were injected with an infective dose of P. aeruginosa PAO1 wild-type and
P. aeruginosa PAO1 containing plasmids derived from pETS130 (Table S1), which encode transcriptional
fusions of the nrdA and nrdJ promoters with GFP and E2Crimson that were previously constructed in
our laboratory (pETS134, pETS180, pETS226, and pETS227) [14,19]. As a control, a group of larvae was
only injected with 1× PBS (Fisher Scientific, Madrid, Spain). The larvae were incubated at 37 ◦C for
16 h and until death (20 h for the infected larvae). After each time point, the larvae were anesthetized
on ice for 10 min. Afterward, the tails of the larvae were cut off, and the hemolymph was collected into
Eppendorf tubes while kept on ice to prevent melanization. The hemolymph from each group of larvae
was pooled, and 1× PBS was added until 100 µL total volume was reached. Relative fluorescence
was measured from the top of a 96-well black, flat-bottom microtiter plate (Fisher Scientific, Madrid,
Spain) in an Infinite® M200 Pro microplate reader (Tecan, Männedorf, Switzerland). The optimized
Z-position was established as 18,000 µm, and the integration time was set as 20 µs. For GFP, the gain
was adjusted to the optimal 142, the excitation wavelength was fixed at 480 nm, and the emission
wavelength was set at 515 nm. For E2Crimson, the optimal gain was determined as 255 nm, and the
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excitation and emission wavelengths were established as 600 and 650 nm, respectively. The results
obtained were analyzed using the GraphPad Prism 8.0 software (San Diego, CA, USA).
After fluorescence quantification, the hemolymph was visualized with an inverted fluorescence
microscope ECLIPSE Ti−S/L100 (Nikon, Tokyo, Japan) coupled with a DS-Qi2 camera (Nikon, Tokyo,
Japan) using a 100×/1.30 oil objective with the GFP and Texas Red filters for green and red fluorescence,
respectively. The images obtained were analyzed using the NIS-Elements microscope imaging software
(Nikon, Tokyo, Japan).
2.7. Bioluminescence Measurements
Relative luminescence of infected larvae was measured in a 6-well microtiter plate (Caplugs
Evergreen, Buffalo, NY, USA) in a Spark®multimode microplate reader (Tecan, Männedorf, Switzerland)
with an integration time of 1000 ms. The results obtained were analyzed using GraphPad Prism 8.0
software (San Diego, CA, USA). The ImageQuant™ LAS 4000 mini imager (GE Healthcare, Chicago,
IL, USA) allowed us to take chemiluminescence pictures of the worms over different time points of
infection. Exposure time was optimized to 30 s, and images were afterward edited with ImageJ FIJI
(Version 1.52p, National Institutes of Health, Bethesda, MD, USA). Before each measurement, larvae
were anesthetized for ten minutes on ice.
2.8. RNA Extraction, Reverse Transcription, and Real-Time PCR
G. mellonella larvae were injected with an infective dose of P. aeruginosa PAO1 wild-type and
incubated for about 16 h at 37 ◦C. Then, the larvae were anesthetized on ice for 10 min. Subsequently,
the tails of the larvae were cut off using a size 23 sterile surgical blade (Paramount Surgimed, New
Delhi, India), and the hemolymph was collected into Eppendorf tubes while kept on ice to avoid
melanization. The hemolymph from each group of larvae was pooled, and hemocytes were pelleted by
centrifuging at 1000× g for 5 min at 4 ◦C. The cell-free hemolymph was treated with RNAprotect®
Bacteria Reagent (Qiagen, Hilden, Germany), as stated in the manufacturer’s handbook for subsequent
RNA purification. As a reference, P. aeruginosa PAO1 wild-type cells were grown in LB medium to
mid-exponential growth phase (OD550 = 0.5) and then treated with RNAprotect®.
In both samples, the RNA was purified using the GeneJET™ RNA Purification Kit (Thermo
Scientific, Madrid, Spain) according to the manufacturer’s instructions. DNase (Turbo DNA-free™,
Applied Biosystems, Foster City, CA, USA) was used to remove DNA contamination that was verified
by PCR. For cDNA synthesis, RNA was quantified using a NanoDrop™ 1000 spectrophotometer
(Thermo Scientific, Madrid, Spain), and 0.25 µg of RNA was reverse transcribed using Maxima Reverse
Transcriptase (Thermo Scientific, Madrid, Spain) along with random hexamer primers (Thermo
Scientific, Madrid, Spain) by following the manufacturer’s guidelines.
Quantitative real-time PCR (qRT-PCR) was performed using PowerUp™ SYBR™ Green Master
Mix (Applied Biosystems, Foster City, CA, USA) in a StepOnePlus™ Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA) according to the manufacturer’s protocol. All of the qRT-PCR
reactions used specific gene primers that are listed in Table S2. The gapA gene was used as an internal
standard as its expression is vital during P. aeruginosa growth. Three replicates were performed for each
sample, and the entire experiment was independently performed twice. The results were analyzed
using the comparative Ct (cycle threshold) method (∆∆Ct) and plotted using GraphPad Prism 8.0
software (San Diego, CA, USA).
2.9. Other Methods
G. mellonella larvae were injected with an infective dose of P. aeruginosa PAO1 wild-type, P. aeruginosa
PAO1 expressing GFP (PAO1::eGFP), and P. aeruginosa PAO1 expressing the luxCDABE genes (PAO1::lux)
followed by incubation at 37 ◦C for about 19 h or until death. The larvae infected with PAO1 wild-type
and PAO1::eGFP were imaged in a Gel Doc™ XR+ imaging system (Bio-Rad, Hercules, CA, USA)
using the Alexa Fluor™ 488 protocol with UV trans-illumination. The same larvae were also imaged
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directly under an LSM 800 confocal laser scanning microscope (Zeiss, Jena, Germany) with the 20×/0.8
air and 63×/1.4 oil objectives. The larvae infected with PAO1 wild-type and PAO1::lux were visualized
in the ImageQuant™ LAS 4000 mini (GE Healthcare, Chicago, IL, USA) and Odyssey® Fc (LI-COR,
Lincoln, NE, USA) imaging systems using the chemiluminescence method with a 30-s exposition time.
In the LAS 4000 mini, the larvae were also pictured using the digitization (epi-illumination) method
with an exposure time of 1/30 s. As a reference, free bacteria grown in LB media were also imaged with
the same methodologies. Images were analyzed using ImageJ FIJI (Version 1.52p, National Institutes of
Health, Bethesda, MD, USA) and GraphicConverter (Version 11, Lemke Software, Peine, Germany).
3. Results and Discussion
3.1. Optimization of Reporter Genes for Gene Expression Studies
To first determine the best reporter gene for bacterial gene expression studies in G. mellonella, larvae
were infected with two P. aeruginosa PAO1 strains, each harboring either green fluorescent protein (GFP)
or luciferase genes (lux) inserted in its chromosome (PAO1::eGFP and PAO1::lux, respectively). These
were chosen as they represent the most commonly used non-enzymatic reporter genes. The larvae
were incubated at 37 ◦C until their death, which is when sufficient bacterial load should be available
to detect its fluorescence or bioluminescence. Then, the larvae were visualized in imaging systems
readily available in the laboratory.
The first instrument tested was the Gel Doc™ imaging system (see Materials and Methods).
This instrument or an analog is readily available in most laboratories as it is commonly used to image
protein and nucleic acid gels, blots, and macroarrays. This system also supports multiple detection
methods, including fluorescence and colorimetric detection [20]. Using the preset Alexa Fluor™ 488
protocol, P. aeruginosa PAO1 WT and PAO1::eGFP on LB plates were first imaged. As seen in Figure 1A,
green luminescence was seen with PAO1::eGFP but not with the wild-type strain as it is not expressing
a fluorescent protein. The next step was to image larvae infected with the two previous strains to
see whether the same result could be obtained. Unfortunately, both groups of larvae showed some
green fluorescence around the body’s edges that is most likely autofluorescence. Specific bacterial
fluorescence was not seen inside the larvae as the fluorescence probably cannot be detected through
the larval cuticle. Additionally, we tried to image the same samples under a confocal microscope.
Entire larvae were visualized using the green (488 nm) laser for PAO1::eGFP and the differential
interference contrast (DIC) mode for non-fluorescent bacteria (PAO1 WT). As seen in Figure 1B, no
bacterial fluorescence could be seen as the laser could not penetrate the cuticle of the larvae. Instead,
only green autofluorescence was again detected in both types of samples. In all cases, the use of protein
fluorescence was not the best option for monitoring gene expression during a G. mellonella infection as
it cannot overcome the larval cuticle. Furthermore, as seen in our experiments, the particularly high
autofluorescent background of the worms can hinder the precise quantification of the protein.
As the fluorescence detection systems were not successful, the next step was to try using bioluminescence.
This methodology is commonly used to study ongoing biological processes in living organisms [21].
P. aeruginosa PAO1 WT and PAO1::lux on LB plates were first imaged in two different devices,
the ImageQuant™ LAS 4000 mini and the Odyssey® Fc imaging systems (see Materials and Methods).
These two instruments or equivalent ones are commonly found in laboratories as they are used to
analyze chemiluminescent Western blots, among other applications. In both systems, the LB plate
with P. aeruginosa PAO1::lux showed a high amount of bioluminescence while the PAO1 WT plate did
not. The same result was obtained with the larvae infected with P. aeruginosa PAO1::lux and PAO1 WT
(Figure 1C). One finding worth emphasizing is that the larvae that were not infected with bacteria
expressing the lux genes had almost negligible background bioluminescence. Thus far, it appears that
bioluminescence is the best method for studying bacterial infections using whole larvae.
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Figure 1. Visualization of G. mellonella larvae using different imaging methodologies. P. aeruginosa
PAO1 wild-type (WT) and PAO1::eGFP strains were imaged using (A) the Gel Doc™ imaging system
and (B) the LSM 800 confocal microscope. Free bacteria were imaged on LB media as well as inside
G. mellonella larvae. (C) P. aeruginosa PAO1 wild-type (WT) and PAO1::lux were imaged as free bacteria
on an LB plate and within G. mellonella larvae using the ImageQuant™ LAS 4000 mini and Odyssey®
Fc imaging systems.
3.2. Determining Autofluorescence in Galleria mellonella
As was clearly shown previously, the larval cuticle is impermeable to the light emitted by the
different fluorescent proteins used in this work. As a way to overcome the cuticle’s opacity, further
experiments were done to try to measure the signal emitted directly from fluorescent proteins present
in the hemolymph extracted from infected larvae. For this, G. mellonella larvae were injected with
P. aeruginosa PAO1 wild-type (WT), two P. aeruginosa PAO1 strains expressing GFP (PnrdA-GFP [pETS134]
and PnrdJ-GFP [pETS180]), two P. aeruginosa PAO1 strains expressing E2Crimson (PnrdA-E2Crimson
[pETS226] and PnrdJ-E2Crimson [pETS227]), and PBS. The hemolymph from each group was extracted,
and then, green and red fluorescence was measured in a Tecan plate reader using GFP (Figure 2A) and
E2Crimson (Figure 2B) settings, respectively. At 16 and 20 h post-infection, P. aeruginosa PAO1 WT
presented an inherent amount of both green and red autofluorescence when compared to the bacterial
strains expressing GFP and E2Crimson (Figure 2A,B). Similar results were also seen with bacteria
Microorganisms 2020, 8, 1798 7 of 14
expressing mOrange and eYFP (data not shown). At 16 and 20 h post-injection, the hemolymph of
larvae injected with PBS also had high autofluorescence with both GFP and E2Crimson that resulted
in values comparable to the ones obtained with the expression vectors. The only difference between
non-infected and infected larvae is that PAO1 WT causes hemocyte proliferation within the larvae
in response to the infection [22], so it seems that hemocytes also possess intrinsic autofluorescence.
Additionally, it can be noticed that the PnrdA strains show more fluorescence than the PnrdJ strains,
but this is related to their genetic expression during infection, as we previously reported [14]. When
quantifying GFP and E2Crimson fluorescence, all strains follow the same pattern, and it is undeniable
that G. mellonella’s autofluorescence cannot pass unnoticed any longer.
Figure 2. Autofluorescence studies in the hemolymph of G. mellonella. (A) Quantification of green
autofluorescence, in relative fluorescence units per milliliter of hemolymph, using larvae infected with
different P. aeruginosa strains and PBS (negative control) at 16 and 20 h post-infection. (B) Quantification
of red autofluorescence, in relative fluorescence units per milliliter of hemolymph, using larvae
infected with different P. aeruginosa strains and PBS (negative control) at 16 and 20 h post-infection.
(C) Phase contrast merged with green and red fluorescence images of hemolymph extracted from larvae
infected with P. aeruginosa PAO1 wild-type showing the green and red autofluorescence of hemocytes,
respectively. (D) Phase contrast only and phase contrast merged with green fluorescence images of
hemolymph extracted from larvae infected with P. aeruginosa PAO1 PnrdA-GFP. (E) Phase contrast only
and phase contrast merged with red fluorescence images of hemolymph extracted from larvae infected
with P. aeruginosa PAO1 PnrdA-E2Crimson.
Additionally, the same hemolymph was visualized under a fluorescence microscope to reinforce
the plate reader results. In Figure 2C, the hemolymph of larvae infected with P. aeruginosa PAO1 WT
was used to observe the natural green and red autofluorescence of hemocytes. Hemolymph containing
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P. aeruginosa PAO1 PnrdA-GFP appears in Figure 2D, where bacteria can be seen expressing green
fluorescence along with the green autofluorescence of hemocytes. The same happens in the hemolymph
containing P. aeruginosa PAO1 PnrdA-E2Crimson, as seen in Figure 2E, where bacteria and hemocytes
appear red when merging the phase contrast and red channels.
Fluorescent promoter probe vectors are widely used for gene expression analysis under different
conditions [23,24], so these vectors would be ideal to use in a G. mellonella infection. However, the results
obtained with the hemolymph studies confirmed that fluorescent protein vectors could not be used in
G. mellonella. The autofluorescence of hemocytes during P. aeruginosa infections poses a critical limitation
in using fluorescent vectors as changes in fluorescence expression cannot be easily distinguished.
For this reason, vectors expressing bioluminescence seem like the most optimal alternative.
3.3. Construction of pETS220-BIATlux Vector and nrd Fusions
To study gene expression using bioluminescence in G. mellonella larvae, a vector containing the
lux genes was first needed. The approach was to create a promoter probe vector that could be used
with any gene promoter and not just a vector containing the promoters required for our purpose.
For this, the pETS130 vector [14] was modified by replacing the cat and mut3-GFP variant genes
with the luxCDABE genes, thus generating the pETS220-BIATlux (pETSlux) vector with a final size
of 10,677 base pairs (see Materials and Methods). This plasmid (Figure 3) offers several advantages:
(1) it has a multi-cloning site (MCS) containing unique restriction sites for easy insertion of the
promoter fragment of interest, (2) it carries gentamicin resistance for simple selection, and (3) it is a
broad-host-range vector as it contains both pBBR1 oriV and pBBR1 Rep that allow its replication in a
variety of microorganisms [25].
Once the vector was successfully constructed, the promoters of interest were cloned using the
unique cutter restriction enzymes within the multi-cloning site. As a proof of concept, the promoters
of the different P. aeruginosa ribonucleotide reductase genes (nrd) (PnrdA, PnrdJ, PnrdD, and PnrdR)
were all included to efficiently detect differences in gene expression during infection. These genes were
previously characterized by our group during infection in Drosophila melanogaster [14] and Danio rerio [24].
As a negative control, a fragment of the anr gene similar in size to the promoters used was inserted
in the vector using the MCS. This was done to detect the vector’s intrinsic levels of bioluminescence.
After all the nrd promoter fusions were successfully constructed, the vectors were electrotransformed
into P. aeruginosa PAO1 wild-type cells. Although the vector is relatively large (>10 kb), all the DNA
manipulations were carried out effortlessly, and the vector was easily electroporated into the PAO1
cells in the first attempt. Finally, positive clones were selected using gentamicin. Using the pETSlux for
cloning the different promoters facilitated the process in many ways: the promoters were easily cloned
using the MCS, the promoter fusions could be cultured in both E. coli and P. aeruginosa, and positive
clones were readily detected using gentamicin selection. These advantages demonstrate the high
practicality of the pETSlux vector in bacterial gene expression studies.
3.4. Monitoring a P. Aeruginosa Infection in G. Mellonella Larvae
As proof of concept for our bioluminescence vector, we evaluated the expression of the well-known
ribonucleotide reductase (nrd) genes [15,16] to track an in vivo infection. G. mellonella larvae were
injected with the P. aeruginosa PAO1 wild-type strains containing the different nrd promoter-lux fusion
constructions. Relative luminescence was measured for each larval group at several time points during
the infection course: 8, 14, 17, and 20 h post-infection with the latter corresponding to larval death.
The bioluminescence within the larvae should vary depending on the level of expression of the different
nrd genes as regulated by the promoters controlling the lux operon. In effect, the infection could be
monitored at different time points as the relative luminescence units (RLU) within the larvae increased
over time for the different strains (Figure 4A). The expression of both PnrdR-lux and PnrdJ-lux started
rising at 14 h post-infection (4059 and 2740 RLU, respectively) and continued escalating throughout
the remainder of the infection. In contrast, PnrdD-lux and PnrdA-lux both had a lower expression that
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did not reach similar levels as PnrdJ-lux (about 2.5 × 105 RLU) until the larvae were dead. At 20 h
post-infection (death), PnrdR-lux had the highest RLU values (3.5 × 106), thus indicating that nrdR is
highly expressed not only at death but throughout the whole infection. The negative control, Anr-lux,
had low levels of bioluminescence that ranged from 36 to 2600 RLU, which were consistent with
background signals caused by leaking reporter expression. Despite the leaking, the values of all the
other strains were much higher than Anr-lux at all time points. The highest RLU value obtained with
Anr-lux was only 2600 at 20 h post-infection, which is about 1340 times less than the corresponding
value for PnrdR-lux (3.5 × 106 RLU).
Figure 3. Map of the pETS220-BIATlux (pETSlux) promoter-probe vector. The luxCDABE genes were
inserted into the backbone of the pETS130 vector. Relevant genetic elements include: gentamicin
resistance (GmR) imparted by aacC1, plasmid mobilization functions encoded by mob, and pBBR1 oriV
and pBBR1 Rep as the replication origin and replication protein, respectively, that are essential for
broad-host-range capability. Unique cutter restriction enzymes within the multi-cloning site (MCS)
are shown in bold. All genes are represented in scale according to the total length of the plasmid.
The vector map was designed with SnapGene® version 5.0.8 (GSL Biotech, San Diego, CA, USA).
Bioluminescence images were also taken at 17 and 20 h post-infection for each of the larvae
conditions using the ImageQuant™ LAS 4000 mini imaging system (Figure 4B). The images show that
the larvae emitted more or less bioluminescence according to their respective nrd expression (depending
on the RNR class expressed), which coincided with the results obtained in Figure 4A. Additionally,
the induction in the expression of the different nrd genes during the infection was quantified (Figure 4C).
Anr-lux (negative control) displayed a luminescent background signal, as previously mentioned, which
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was subtracted from each of the strains and time points. Therefore, the values that appear for each
strain in Figure 4C correspond to its induction factor of expression compared to itself at the initial stage
of infection (8 h post-infection). A high induction in nrdR expression was distinctly noticed during
all time points (119, 18,217, and 106,174-fold induction at 14, 17, and 20 h, respectively), followed by
nrdJ (73, 3988, and 6706-fold induction) and nrdD (12, 543, and 3557-fold induction) at the same time
points. On the other hand, a small induction (4–46-fold) in nrdA expression was seen in the first hours
until it suddenly increased at the last time point (up to 6838 times). However, this induction value
was still considerably smaller than the one seen with the nrdR gene (106,174) at the same time point.
A broadened view of Figure 4 confirmed the shift of nrd expression during a P. aeruginosa infection in
G. mellonella larvae that was possible to observe and monitor due to the lux constructions. Furthermore,
the shift seen corresponds with previous results obtained in our lab. In the Drosophila melanogaster
and Danio rerio infection models, the expression of nrdJ and nrdD (RNR class II and III, respectively)
was also highly induced during the course of a P. aeruginosa infection [14,24]. This demonstrates the
importance of anaerobic environments for the in vivo expression of these RNR classes [14,16,26].
Figure 4. Study of a P. aeruginosa PAO1 infection in G. mellonella larvae using the different lux constructions.
(A) Measurements of relative luminescence (RLU) in G. mellonella during several time points after infection
within the different strains. (B) Images of G. mellonella larval bioluminescence taken with the ImageQuant™
LAS 4000 mini imager at 17 and 20 h post-infection and visualized using the Gem lookup table from
ImageJ FIJI. (C) Bioluminescence induction factors during the different time points (14, 17, and 20 h
post-infection). Anr-lux background was subtracted from each of the strains.
Another approach for measuring gene expression during infection in G. mellonella was attempted
using qRT-PCR. For this, a protocol to extract RNA from the bacterial cells inside the G. mellonella larvae
was initially optimized (Figure 5A). First, larvae were injected with an infection dose of P. aeruginosa
PAO1 wild-type (WT) and then kept at 37 ◦C for about 16 h. This time point was chosen based on
previous growth curves done with PAO1 WT in G. mellonella that revealed that at 16 h post-infection,
close to 108 bacterial cells per milliliter were present within the larvae (Figure 5B). According to the
GeneJET™ RNA purification kit protocol, a bacterial concentration near 109 is recommended for
optimal RNA yield. After incubation, the larvae were anesthetized on ice for 10 min before cutting
their tail off to extract the hemolymph. The hemolymph from each larvae group was pooled and then
centrifuged at low speed for 5 min at 4 ◦C to remove the hemocytes. Up to this point, it is important
to maintain the hemolymph on ice to prevent melanization. The cell-free hemolymph containing
PAO1 WT was treated with RNAprotect® and afterward used for RNA extraction, cDNA preparation,
and qRT-PCR analysis. By using this optimized protocol, P. aeruginosa PAO1 cells that were infecting
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G. mellonella larvae in vivo were able to be isolated for efficient RNA purification, which yielded high
and pure RNA concentrations (Table S3) that were successfully used in downstream applications.
Figure 5. Gene expression studies during a P. aeruginosa infection in G. mellonella. (A) Schematic
representation of the steps involved in the optimized RNA extraction protocol for bacterial cells derived
from a G. mellonella infection. Created with BioRender.com. (B) P. aeruginosa PAO1 wild-type (WT)
growth curve in G. mellonella larvae that was determined by calculating CFU/mL at different time points
after infection as well as at death (last point). Samples for qRT-PCR were taken when the bacteria were
in the exponential growth phase (close to 108 CFU/mL) as indicated by the arrow. (C) Fold change of
nrd and anaerobic (norC) genes determined by qRT-PCR during PAO1 WT infection compared to PAO1
WT cells grown to exponential phase in LB medium. The gap gene was used as an internal standard.
The values shown are the average from two independent experiments, and the error bars indicate a
positive standard deviation.
The RNA expression of the infection cells was analyzed relative to the gene expression in P. aeruginosa
PAO1 wild-type cells grown in LB medium to a mid-exponential growth phase. This control was selected
based on the growth curve seen in Figure 5B that shows that the bacterial cells within the larvae are in the
mid-exponential growth phase during sample collection. The growth curve also indicates that an active
DNA synthesis is underway due to the involvement of RNR during the infection process. To ensure the
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reaction specificity of the qRT-PCR results, a melting curve analysis was performed, which showed
a single, pure amplicon for each of the genes assessed (Figure S1). The results were then analyzed
using the comparative Ct (cycle threshold) method (∆∆Ct) by comparing the Cts of the different
genes in a PAO1 WT infection against the Cts of the same genes in a PAO1 WT exponential culture,
and the transcript levels of each gene were normalized using the gapA internal control. Differences
in the expression of the different nrd genes could be clearly seen (Figure 5C). The highest inductions
were seen with nrdR and nrdJ, which were 7.7 and 7.5 times, respectively, more induced in infection
than in planktonic culture. Less induction was seen with nrdA (3.1-fold change), while nrdD only
had a 1.7-fold change induction. A 5.3-fold increase in the expression of the norC gene, a marker of
anaerobiosis, indicated a decrease in oxygen levels, leading to a shift in the anaerobic metabolism
of PAO1 WT during infection. When compared to the results obtained with the different pETSlux
constructions, the RNR expression pattern is very similar except for nrdD and nrdA since PnrdD-lux
had higher expression than PnrdA-lux. It is important to keep in mind that the RNA was extracted
about 1 h before the time point used in the pETSlux measurements, and gene expression depends
on the metabolic state of the bacteria at the time of RNA extraction. Therefore, measurements using
pETSlux are more efficient since gene expression can be measured in vivo at multiple time points
(independent of bacterial concentration inside the larvae) without much manipulation of the larvae
or bacteria. Nevertheless, both the bioluminescence and qRT-PCR experiments revealed that nrdR
is significantly induced during a P. aeruginosa infection. Although nrdR expression was reported to
increase in vitro when interacting with T84 cells [26], this is the first time that nrdR induction is reported
in an in vivo infection experiment. Nevertheless, further work is needed to elucidate its biological role
under these specific conditions.
In this study, we demonstrated the limitation with the use of fluorescent vectors in Galleria mellonella
due to its intrinsic autofluorescence. For this reason, a promoter probe vector containing bioluminescence
expression was constructed that offers a simple and effective method for monitoring gene expression
in vivo using the G. mellonella animal model of infection. Furthermore, an RNA extraction protocol for
bacterial cells from within G. mellonella larvae was optimized to enable the study of transcriptional
levels of genes during an in vivo infection. These findings will allow for a better understanding of the
in vivo infection process of different bacteria in a setting that mimics mammalian body temperature
and pathogen–mammalian host interactions that can only be achieved in an economical and ethical
manner when using the G. mellonella model.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/2076-2607/8/11/1798/
s1, Table S1: Bacterial strains and plasmids used in this study, Table S2: Primers used in this study, Table S3: RNA
quality, Figure S1: qRT-PCR melting curves.
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